{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:31:51Z","timestamp":1793050311677,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K17076"],"award-info":[{"award-number":["19K17076"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["24-11 and 27-6"],"award-info":[{"award-number":["24-11 and 27-6"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["24-11 and 27-6"],"award-info":[{"award-number":["24-11 and 27-6"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["24-11 and 27-6"],"award-info":[{"award-number":["24-11 and 27-6"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dk0307062h0001 and 16ak0101044h0001"],"award-info":[{"award-number":["16dk0307062h0001 and 16ak0101044h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dk0307062h0001 and 16ak0101044h0001"],"award-info":[{"award-number":["16dk0307062h0001 and 16ak0101044h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dk0307062h0001 and 16ak0101044h0001"],"award-info":[{"award-number":["16dk0307062h0001 and 16ak0101044h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To examine the role of neuroplasticity in the pathology of psychiatric disorders, we measured cerebrospinal fluid (CSF) neuroplasticity-associated protein levels. Participants were 94 patients with schizophrenia, 68 with bipolar disorder (BD), 104 with major depressive disorder (MDD), and 118 healthy controls, matched for age, sex, and ethnicity (Japanese). A multiplex immunoassay (22-plex assay) was performed to measure CSF neuroplasticity-associated protein levels. Among 22 proteins, 11 were successfully measured in the assay. CSF amyloid precursor protein (APP) and glial cell-derived neurotrophic factor (GDNF) levels were significantly lower in patients with schizophrenia, and CSF APP and neural cell adhesion molecule (NCAM)-1 levels were significantly lower in patients with BD, than in healthy controls (all\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Positive and Negative Syndrome Scale total, positive, and general scores were significantly and positively correlated with CSF hepatocyte growth factor (HGF) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and S100 calcium-binding protein B (S100B) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) levels in patients with schizophrenia. Young mania-rating scale score was significantly and positively correlated with CSF S100B level in patients with BD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Hamilton Depression Rating Scale, core, sleep, activity, somatic anxiety, and delusion subscale scores were significantly and positively correlated with CSF HGF level, while sleep subscale score was positively correlated with CSF S100B and VEGF receptor 2 levels in patients with MDD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Our results suggest that CSF APP, GDNF, and NCAM-1 levels are associated with psychiatric disorders, and that CSF HGF, S100B, and VEGF receptor 2 levels are related to psychiatric symptoms.\n                  <\/jats:p>","DOI":"10.1038\/s41398-020-0843-5","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T13:03:28Z","timestamp":1590066208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-2075","authenticated-orcid":false,"given":"Shinsuke","family":"Hidese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-7283","authenticated-orcid":false,"given":"Daimei","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tsumagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-3790","authenticated-orcid":false,"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"843_CR1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eurpsy.2018.02.003","volume":"50","author":"G Chelini","year":"2018","unstructured":"Chelini, G., Pantazopoulos, H., Durning, P. & Berretta, S. The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia. Eur. Psychiatry 50, 60\u201369 (2018).","journal-title":"Eur. Psychiatry"},{"key":"843_CR2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fpsyt.2017.00238","volume":"8","author":"LJ De Picker","year":"2017","unstructured":"De Picker, L. J., Morrens, M., Chance, S. A. & Boche, D. Microglia and brain plasticity in acute psychosis and schizophrenia illness course: a meta-review. Front. Psychiatry 8, 238 (2017).","journal-title":"Front. Psychiatry"},{"key":"843_CR3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/ejn.12489","volume":"39","author":"AJ Pocklington","year":"2014","unstructured":"Pocklington, A. J., O\u2019Donovan, M. & Owen, M. J. The synapse in schizophrenia. Eur. J. Neurosci. 39, 1059\u20131067 (2014).","journal-title":"Eur. J. Neurosci."},{"key":"843_CR4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/15622975.2013.830775","volume":"15","author":"R Machado-Vieira","year":"2014","unstructured":"Machado-Vieira, R., Soeiro-De-Souza, M. G., Richards, E. M., Teixeira, A. L. & Zarate, C. A. Jr. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J. Biol. Psychiatry 15, 84\u201395 (2014).","journal-title":"World J. Biol. Psychiatry"},{"key":"843_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2012.12.012","volume":"43","author":"WN Marsden","year":"2013","unstructured":"Marsden, W. N. Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 43, 168\u2013184 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"843_CR6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00213-018-4950-4","volume":"235","author":"MJF Levy","year":"2018","unstructured":"Levy, M. J. F. et al. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression. Psychopharmacology 235, 2195\u20132220 (2018).","journal-title":"Psychopharmacology"},{"key":"843_CR7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jad.2017.12.026","volume":"233","author":"R Machado-Vieira","year":"2018","unstructured":"Machado-Vieira, R. Lithium, stress, and resilience in bipolar disorder: deciphering this key homeostatic synaptic plasticity regulator. J. Affect. Disord. 233, 92\u201399 (2018).","journal-title":"J. Affect. Disord."},{"key":"843_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neubiorev.2018.04.002","volume":"90","author":"JB Price","year":"2018","unstructured":"Price, J. B. et al. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. Neurosci. Biobehav. Rev. 90, 212\u2013220 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"843_CR9","doi-asserted-by":"crossref","unstructured":"Umemori J., Winkel F., Didio G., Llach Pou M., Castren E. iPlasticity: induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants. Psychiatry Clin. Neurosci. (2018).","DOI":"10.1111\/pcn.12683"},{"key":"843_CR10","first-page":"4605971","volume":"2017","author":"YJ Huang","year":"2017","unstructured":"Huang, Y. J., Lane, H. Y. & Lin, C. H. New treatment strategies of depression: based on mechanisms related to neuroplasticity. Neural Plast. 2017, 4605971 (2017).","journal-title":"Neural Plast."},{"key":"843_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mp.2017.225","volume":"23","author":"ER Workman","year":"2018","unstructured":"Workman, E. R., Niere, F. & Raab-Graham, K. F. Engaging homeostatic plasticity to treat depression. Mol. Psychiatry 23, 26\u201335 (2018).","journal-title":"Mol. Psychiatry"},{"key":"843_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.07.084","volume":"309","author":"T Bartsch","year":"2015","unstructured":"Bartsch, T. & Wulff, P. The hippocampus in aging and disease: from plasticity to vulnerability. Neuroscience 309, 1\u201316 (2015).","journal-title":"Neuroscience"},{"key":"843_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-neuro-080317-062155","volume":"41","author":"HR Monday","year":"2018","unstructured":"Monday, H. R., Younts, T. J. & Castillo, P. E. Long-term plasticity of neurotransmitter release: emerging mechanisms and contributions to brain function and disease. Annu. Rev. Neurosci. 41, 299\u2013322 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"843_CR14","doi-asserted-by":"crossref","first-page":"318596","DOI":"10.1155\/2013\/318596","volume":"2013","author":"H Hagihara","year":"2013","unstructured":"Hagihara, H., Takao, K., Walton, N. M., Matsumoto, M. & Miyakawa, T. Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. Neural Plast. 2013, 318596 (2013).","journal-title":"Neural Plast."},{"key":"843_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1503\/jpn.100048","volume":"36","author":"M Thompson Ray","year":"2011","unstructured":"Thompson Ray, M., Weickert, C. S., Wyatt, E. & Webster, M. J. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J. Psychiatry Neurosci. 36, 195\u2013203 (2011).","journal-title":"J. Psychiatry Neurosci."},{"key":"843_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2017.06.009","volume":"46","author":"A Sheldrick","year":"2017","unstructured":"Sheldrick, A., Camara, S., Ilieva, M., Riederer, P. & Michel, T. M. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study. Eur. Psychiatry 46, 65\u201371 (2017).","journal-title":"Eur. Psychiatry"},{"key":"843_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8454-7-1","volume":"7","author":"JG Veening","year":"2010","unstructured":"Veening, J. G. & Barendregt, H. P. The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review. Cerebrospinal Fluid Res. 7, 1 (2010).","journal-title":"Cerebrospinal Fluid Res."},{"key":"843_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","volume":"128","author":"L Sakka","year":"2011","unstructured":"Sakka, L., Coll, G. & Chazal, J. Anatomy and physiology of cerebrospinal fluid. Eur. Ann. Otorhinolaryngol. Head. Neck Dis. 128, 309\u2013316 (2011).","journal-title":"Eur. Ann. Otorhinolaryngol. Head. Neck Dis."},{"key":"843_CR19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/geronb\/gbu096","volume":"69","author":"BS Diniz","year":"2014","unstructured":"Diniz, B. S. et al. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. J. Gerontol. B Psychol. Sci. Soc. Sci. 69, 845\u2013851 (2014).","journal-title":"J. Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"843_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1461145709991015","volume":"13","author":"A Pillai","year":"2010","unstructured":"Pillai, A. et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J. Neuropsychopharmacol. 13, 535\u2013539 (2010).","journal-title":"Int J. Neuropsychopharmacol."},{"key":"843_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.schres.2009.07.022","volume":"115","author":"A Kale","year":"2009","unstructured":"Kale, A. et al. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naive psychotic patients. Schizophr. Res. 115, 209\u2013214 (2009).","journal-title":"Schizophr. Res."},{"key":"843_CR22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.mp.4000743","volume":"5","author":"C Hock","year":"2000","unstructured":"Hock, C. et al. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol. Psychiatry 5, 510\u2013513 (2000).","journal-title":"Mol. Psychiatry"},{"key":"843_CR23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/jnnp.2006.093427","volume":"77","author":"J Steiner","year":"2006","unstructured":"Steiner, J., Bielau, H., Bernstein, H. G., Bogerts, B. & Wunderlich, M. T. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J. Neurol. Neurosurg. Psychiatry 77, 1284\u20131287 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"843_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/15622975.2014.952776","volume":"16","author":"FM Schmidt","year":"2015","unstructured":"Schmidt, F. M., Mergl, R., Stach, B., Jahn, I. & Schonknecht, P. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. World J. Biol. Psychiatry 16, 106\u2013113 (2015).","journal-title":"World J. Biol. Psychiatry"},{"key":"843_CR25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.mp.4001548","volume":"9","author":"M Rothermundt","year":"2004","unstructured":"Rothermundt, M. et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol. Psychiatry 9, 897\u2013899 (2004).","journal-title":"Mol. Psychiatry"},{"key":"843_CR26","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","volume":"39","author":"J Jakobsson","year":"2014","unstructured":"Jakobsson, J. et al. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients. Neuropsychopharmacology 39, 2349\u20132356 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"843_CR27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000054922","volume":"44","author":"HJ Grabe","year":"2001","unstructured":"Grabe, H. J., Ahrens, N., Rose, H. J., Kessler, C. & Freyberger, H. J. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 44, 88\u201390 (2001).","journal-title":"Neuropsychobiology"},{"key":"843_CR28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jpsychires.2019.03.024","volume":"113","author":"T Mizui","year":"2019","unstructured":"Mizui, T. et al. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia. J. Psychiatr. Res. 113, 190\u2013198 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"843_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pnpbp.2017.02.016","volume":"76","author":"S Hidese","year":"2017","unstructured":"Hidese, S. et al. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 76, 12\u201318 (2017).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"843_CR30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","volume":"9","author":"PJ Tighe","year":"2015","unstructured":"Tighe, P. J., Ryder, R. R., Todd, I. & Fairclough, L. C. ELISA in the multiplex era: potentials and pitfalls. Proteom. Clin. Appl. 9, 406\u2013422 (2015).","journal-title":"Proteom. Clin. Appl."},{"issue":"Suppl 20","key":"843_CR31","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl 20), 22\u201333 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"843_CR32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1819.2005.01408.x","volume":"59","author":"T Otsubo","year":"2005","unstructured":"Otsubo, T. et al. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin. Neurosci. 59, 517\u2013526 (2005).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"843_CR33","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association.","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (American Psychiatric Association, Washington, 1994).","edition":"4th ed."},{"key":"843_CR34","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association.","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J. Am. Med. Assoc. 310, 2191\u20132194 (2013).","journal-title":"J. Am. Med. Assoc."},{"key":"843_CR35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"843_CR36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1440-1819.1998.00425.x","volume":"52","author":"Y Igarashi","year":"1998","unstructured":"Igarashi, Y. et al. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect. Psychiatry Clin. Neurosci. 52, 467\u2013470 (1998).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"843_CR37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429\u2013435 (1978).","journal-title":"Br. J. Psychiatry"},{"key":"843_CR38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","volume":"23","author":"JB Williams","year":"2008","unstructured":"Williams, J. B. et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin. Psychopharmacol. 23, 120\u2013129 (2008).","journal-title":"Int Clin. Psychopharmacol."},{"key":"843_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2006.07.004","volume":"153","author":"H Tabuse","year":"2007","unstructured":"Tabuse, H. et al. The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 153, 61\u201367 (2007).","journal-title":"Psychiatry Res."},{"key":"843_CR40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1520-6394(1998)8:2<80::AID-DA6>3.0.CO;2-I","volume":"8","author":"A Serretti","year":"1998","unstructured":"Serretti, A., Lattuada, E., Cusin, C., Macciardi, F. & Smeraldi, E. Analysis of depressive symptomatology in mood disorders. Depress. Anxiety 8, 80\u201385 (1998).","journal-title":"Depress. Anxiety"},{"key":"843_CR41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","volume":"69","author":"T Inada","year":"2015","unstructured":"Inada, T. & Inagaki, A. Psychotropic dose equivalence in Japan. Psychiatry Clin. Neurosci. 69, 440\u2013447 (2015).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"843_CR42","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1038\/sj.emboj.7600860","volume":"24","author":"C Reinhard","year":"2005","unstructured":"Reinhard, C., Hebert, S. S. & De Strooper, B. The amyloid-beta precursor protein: integrating structure with biological function. EMBO J. 24, 3996\u20134006 (2005).","journal-title":"EMBO J."},{"key":"843_CR43","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.108712","volume":"141","author":"M Nicolas","year":"2014","unstructured":"Nicolas, M. & Hassan, B. A. Amyloid precursor protein and neural development. Development 141, 2543\u20132548 (2014).","journal-title":"Development"},{"key":"843_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnmol.2017.00021","volume":"10","author":"K Wild","year":"2017","unstructured":"Wild, K., August, A., Pietrzik, C. U. & Kins, S. Structure and synaptic function of metal binding to the amyloid precursor protein and its proteolytic fragments. Front. Mol. Neurosci. 10, 21 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"843_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","volume":"70","author":"PR Turner","year":"2003","unstructured":"Turner, P. R., O\u2019Connor, K., Tate, W. P. & Abraham, W. C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70, 1\u201332 (2003).","journal-title":"Prog. Neurobiol."},{"key":"843_CR46","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-017-0108-5","volume":"5","author":"W Araki","year":"2017","unstructured":"Araki, W. et al. Re-evaluation of soluble APP-alpha and APP-beta in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders. Biomark. Res. 5, 28 (2017).","journal-title":"Biomark. Res."},{"key":"843_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2010.08.022","volume":"1357","author":"A Gabelle","year":"2010","unstructured":"Gabelle, A. et al. Correlations between soluble alpha\/beta forms of amyloid precursor protein and Abeta38, 40, and 42 in human cerebrospinal fluid. Brain Res. 1357, 175\u2013183 (2010).","journal-title":"Brain Res."},{"key":"843_CR48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2012.231","volume":"38","author":"J Jakobsson","year":"2013","unstructured":"Jakobsson, J. et al. Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder. Neuropsychopharmacology 38, 664\u2013672 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"843_CR49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1740925X09990111","volume":"4","author":"A Dityatev","year":"2008","unstructured":"Dityatev, A., Bukalo, O. & Schachner, M. Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules. Neuron Glia Biol. 4, 197\u2013209 (2008).","journal-title":"Neuron Glia Biol."},{"key":"843_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/REVNEURO.2001.12.2.95","volume":"12","author":"RC Pierce","year":"2001","unstructured":"Pierce, R. C. & Bari, A. A. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev. Neurosci. 12, 95\u2013110 (2001).","journal-title":"Rev. Neurosci."},{"key":"843_CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2009.11.009","volume":"35","author":"UE Ghitza","year":"2010","unstructured":"Ghitza, U. E. et al. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci. Biobehav. Rev. 35, 157\u2013171 (2010).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"843_CR52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fncel.2015.00154","volume":"9","author":"K Yamamuro","year":"2015","unstructured":"Yamamuro, K., Kimoto, S., Rosen, K. M., Kishimoto, T. & Makinodan, M. Potential primary roles of glial cells in the mechanisms of psychiatric disorders. Front. Cell Neurosci. 9, 154 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"843_CR53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/pcn.12290","volume":"69","author":"C Wang","year":"2015","unstructured":"Wang, C., Aleksic, B. & Ozaki, N. Glia-related genes and their contribution to schizophrenia. Psychiatry Clin. Neurosci. 69, 448\u2013461 (2015).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"843_CR54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","volume":"161","author":"HG Bernstein","year":"2015","unstructured":"Bernstein, H. G., Steiner, J., Guest, P. C., Dobrowolny, H. & Bogerts, B. Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr. Res. 161, 4\u201318 (2015).","journal-title":"Schizophr. Res."},{"key":"843_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pneurobio.2010.09.004","volume":"93","author":"N Takahashi","year":"2011","unstructured":"Takahashi, N., Sakurai, T., Davis, K. L. & Buxbaum, J. D. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog. Neurobiol. 93, 13\u201324 (2011).","journal-title":"Prog. Neurobiol."},{"key":"843_CR56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1100\/tsw.2010.49","volume":"10","author":"S Sharma","year":"2010","unstructured":"Sharma, S. Hepatocyte growth factor in synaptic plasticity and Alzheimer\u2019s disease. Sci. World J. 10, 457\u2013461 (2010).","journal-title":"Sci. World J."},{"key":"843_CR57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/cyto.2001.0875","volume":"14","author":"MA Kern","year":"2001","unstructured":"Kern, M. A. et al. Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions. Cytokine 14, 170\u2013176 (2001).","journal-title":"Cytokine"},{"key":"843_CR58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/pcn.12024","volume":"67","author":"S Yelmo-Cruz","year":"2013","unstructured":"Yelmo-Cruz, S., Morera-Fumero, A. L. & Abreu-Gonzalez, P. S100B and schizophrenia. Psychiatry Clin. Neurosci. 67, 67\u201375 (2013).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"843_CR59","first-page":"20","volume":"7","author":"A Yarlagadda","year":"2010","unstructured":"Yarlagadda, A., Hampe, C. S. & Clayton, A. H. The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia. Psychiatry 7, 20\u201323 (2010).","journal-title":"Psychiatry"},{"key":"843_CR60","doi-asserted-by":"crossref","first-page":"708306","DOI":"10.1155\/2015\/708306","volume":"2015","author":"JP Patel","year":"2015","unstructured":"Patel, J. P. & Frey, B. N. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015, 708306 (2015).","journal-title":"Neural Plast."},{"key":"843_CR61","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A. & Zagzag, D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J. Neuroinflamm. 10, 142 (2013).","journal-title":"J. Neuroinflamm."},{"key":"843_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","volume":"46","author":"MM Nowacka","year":"2012","unstructured":"Nowacka, M. M. & Obuchowicz, E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46, 1\u201310 (2012).","journal-title":"Neuropeptides"},{"key":"843_CR63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4161\/cam.22408","volume":"6","author":"M Tillo","year":"2012","unstructured":"Tillo, M., Ruhrberg, C. & Mackenzie, F. Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity. Cell Adhes. Migr. 6, 541\u2013546 (2012).","journal-title":"Cell Adhes. Migr."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0843-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T08:44:42Z","timestamp":1670229882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0843-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-0843-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"161"}}